BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21703429)

  • 1. Lung-residing metastatic and dormant neuroblastoma cells.
    Edry Botzer L; Maman S; Sagi-Assif O; Meshel T; Nevo I; Bäuerle T; Yron I; Witz IP
    Am J Pathol; 2011 Jul; 179(1):524-36. PubMed ID: 21703429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metastatic microenvironment: lung-derived factors control the viability of neuroblastoma lung metastasis.
    Maman S; Edry-Botzer L; Sagi-Assif O; Meshel T; Yuan W; Lu W; Witz IP
    Int J Cancer; 2013 Nov; 133(10):2296-306. PubMed ID: 23649556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and characterization of novel local and metastatic human neuroblastoma variants.
    Nevo I; Sagi-Assif O; Edry Botzer L; Amar D; Maman S; Kariv N; Leider-Trejo LE; Savelyeva L; Schwab M; Yron I; Witz IP
    Neoplasia; 2008 Aug; 10(8):816-27. PubMed ID: 18683320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PHOX2B is a suppressor of neuroblastoma metastasis.
    Naftali O; Maman S; Meshel T; Sagi-Assif O; Ginat R; Witz IP
    Oncotarget; 2016 Mar; 7(9):10627-37. PubMed ID: 26840262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours.
    Braekeveldt N; Wigerup C; Gisselsson D; Mohlin S; Merselius M; Beckman S; Jonson T; Börjesson A; Backman T; Tadeo I; Berbegall AP; Ora I; Navarro S; Noguera R; Påhlman S; Bexell D
    Int J Cancer; 2015 Mar; 136(5):E252-61. PubMed ID: 25220031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis.
    Izraely S; Sagi-Assif O; Klein A; Meshel T; Tsarfaty G; Pasmanik-Chor M; Nahmias C; Couraud PO; Ateh E; Bryant JL; Hoon DS; Witz IP
    Int J Cancer; 2012 Sep; 131(5):1071-82. PubMed ID: 22025079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hexokinase 2 is a determinant of neuroblastoma metastasis.
    Botzer LE; Maman S; Sagi-Assif O; Meshel T; Nevo I; Yron I; Witz IP
    Br J Cancer; 2016 Mar; 114(7):759-66. PubMed ID: 26986252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PHOX2B Is Associated with Neuroblastoma Cell Differentiation.
    Yang L; Ke XX; Xuan F; Tan J; Hou J; Wang M; Cui H; Zhang Y
    Cancer Biother Radiopharm; 2016 Mar; 31(2):44-51. PubMed ID: 26910576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudolaric acid B inhibits gastric cancer cell metastasis in vitro and in haematogenous dissemination model through PI3K/AKT, ERK1/2 and mitochondria-mediated apoptosis pathways.
    Wang D; Xin Y; Tian Y; Li W; Sun D; Yang Y
    Exp Cell Res; 2017 Mar; 352(1):34-44. PubMed ID: 28132880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
    Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
    Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow.
    Hata JL; Correa H; Krishnan C; Esbenshade AJ; Black JO; Chung DH; Mobley BC
    Arch Pathol Lab Med; 2015 Apr; 139(4):543-6. PubMed ID: 25822764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
    Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
    Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic Analysis of Neuroblastoma-Derived Exosomes: New Insights into a Metastatic Signature.
    Colletti M; Petretto A; Galardi A; Di Paolo V; Tomao L; Lavarello C; Inglese E; Bruschi M; Lopez AA; Pascucci L; Geoerger B; Peinado H; Locatelli F; Di Giannatale A
    Proteomics; 2017 Dec; 17(23-24):. PubMed ID: 28722341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly sensitive assessment of neuroblastoma minimal residual disease in ovarian tissue using RT-qPCR-A strategy for improving the safety of fertility restoration.
    Grèze V; Brugnon F; Chambon F; Halle P; Canis M; Amiot C; Grémeau AS; Pereira B; Yáñez Peralta Y; Tchirkov A; Kanold J
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27734578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ppGalNAc-T13: a new molecular marker of bone marrow involvement in neuroblastoma.
    Berois N; Blanc E; Ripoche H; Mergui X; Trajtenberg F; Cantais S; Barrois M; Dessen P; Kågedal B; Bénard J; Osinaga E; Raguénez G
    Clin Chem; 2006 Sep; 52(9):1701-12. PubMed ID: 16873292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells.
    Zubrilov I; Sagi-Assif O; Izraely S; Meshel T; Ben-Menahem S; Ginat R; Pasmanik-Chor M; Nahmias C; Couraud PO; Hoon DS; Witz IP
    Cancer Lett; 2015 May; 361(1):86-96. PubMed ID: 25725450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene-expression-based analysis of local and metastatic neuroblastoma variants reveals a set of genes associated with tumor progression in neuroblastoma patients.
    Nevo I; Oberthuer A; Botzer E; Sagi-Assif O; Maman S; Pasmanik-Chor M; Kariv N; Fischer M; Yron I; Witz IP
    Int J Cancer; 2010 Apr; 126(7):1570-81. PubMed ID: 19739072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis.
    Casalà C; Gil-Guiñón E; Ordóñez JL; Miguel-Queralt S; Rodríguez E; Galván P; Lavarino C; Munell F; de Alava E; Mora J; de Torres C
    Carcinogenesis; 2013 Feb; 34(2):268-76. PubMed ID: 23108190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of minimal disease in the bone marrow and peripheral blood in neuroblastoma.
    Shono K; Tajiri T; Fujii Y; Suita S
    J Pediatr Surg; 2000 Oct; 35(10):1415-20. PubMed ID: 11051140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.